Search

Theravance Biopharma Inc

Chiusa

17.07 0.12

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

17.05

Massimo

17.09

Metriche Chiave

By Trading Economics

Entrata

-965K

-5.9M

Vendite

3M

21M

P/E

Media del settore

16.385

56.659

EPS

0.07

Margine di Profitto

-28.45

Dipendenti

90

EBITDA

5.9M

839K

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

-0.41% downside

Dividendi

By Acuity

Utili prossimi

9 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

10M

885M

Apertura precedente

16.95

Chiusura precedente

17.07

Theravance Biopharma Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

2 set 2026, 23:56 UTC

Fidelity National Financial shares are higher in after-market trading, recovering from earlier losses but remain below the 20-day moving average.

2 set 2026, 23:56 UTC

MGM Resorts International shares are higher in after-market trading, supported by a broader market response to weaker ADP private payrolls data.

2 set 2026, 23:56 UTC

News

Entergy Corp settled its 2025 forward sale agreements, delivering over 11 million shares for $913 million. Shares are higher in after-market trading.

2 set 2026, 23:56 UTC

Correlated Moves

Equinix Inc. shares are higher in after-market trading, supported by a weaker ADP payrolls report indicating lower job growth than expected.

2 set 2026, 23:56 UTC

Biogen Inc shares are higher in after-market trading, despite no specific news. Broader market dynamics may be influenced by weaker ADP payrolls data.

2 set 2026, 23:56 UTC

Exelixis Inc shares are higher in after-market trading, though no specific news was identified. The broader market reacted to weaker ADP payroll data.

2 set 2026, 23:56 UTC

APA Corp. shares are trading roughly flat in after-market hours. Market sentiment is influenced by weaker ADP payroll data, easing rate hike concerns.

2 set 2026, 23:56 UTC

Abbott Laboratories shares are lower in after-market hours, reflecting a decline since Wednesday's close amid weaker-than-expected job growth reported by ADP.

2 set 2026, 23:56 UTC

Union Pacific Corp shares are lower in after-market hours amid volatility, following disappointing ADP payroll data that may affect Federal Reserve interest rate expectations.

2 set 2026, 23:56 UTC

T Rowe Price Group Inc shares are trading lower in after-market hours following a volatile session amid reactions to weaker-than-expected ADP payroll data.

2 set 2026, 23:52 UTC

Mexico's inflation rate expected to stabilize around 3% amid cautious market sentiment and external risks ahead of September release.

2 set 2026, 23:52 UTC

Mexican Inflation Data Release on September 9, Amid Cautious Optimism and Ongoing Economic Risks.

2 set 2026, 23:52 UTC

Australia's Westpac Consumer Confidence Index set for release on September 8, 2026, amid mixed sentiments and rising economic pressures.

2 set 2026, 23:52 UTC

US ISM Services PMI Expected to Rise Slightly to 54.3, Indicating Continued Expansion Amid Economic Challenges

2 set 2026, 23:52 UTC

Australia's Westpac Consumer Confidence Index set for release amid cautious optimism and external inflation risks on September 8, 2026.

2 set 2026, 23:51 UTC

Dorian LPG Ltd shares are lower in after-market hours, following five consecutive sessions of gains. The decline coincides with a weaker ADP payrolls report.

2 set 2026, 23:51 UTC

Hackett Group Inc shares are lower in after-market hours, continuing a decline since Wednesday's close and trading below their 20-day moving average.

2 set 2026, 23:51 UTC

Champion Homes Inc is rising in after-market trading, supported by gains in the Homebuilding sub-sector. The asset has recovered from earlier session lows.

2 set 2026, 23:51 UTC

Essential Properties Realty Trust shares are higher in after-market trading. Broader market trends and recent economic data may be influencing this movement.

2 set 2026, 23:51 UTC

ETF Constituents
Macro News

State Street Financial Select Sector SPDR ETF rises in after-market hours as weaker job growth eases Fed rate hike concerns and key holdings perform well.

2 set 2026, 23:51 UTC

IQVIA Holdings Inc shares rose in after-market trading, continuing upward momentum amid a broader macroeconomic backdrop following the ADP payrolls report.

2 set 2026, 23:51 UTC

Correlated Moves

Republic Bancorp Inc shares declined in after-hours trading, reflecting broader financial sector weakness amid disappointing job creation data from the ADP report.

2 set 2026, 23:51 UTC

South Plains Financial Inc is trading lower in after-market hours, continuing a trend seen during the regular session amid broader market weakness following a disappointing ADP report.

2 set 2026, 23:51 UTC

Keysight Technologies Inc shares are lower in after-market hours, continuing a decline from earlier in the session amid a challenging trading environment.

2 set 2026, 23:51 UTC

Sylvamo Corp shares are lower in after-market trading, continuing a decline from earlier in the session amid broader market weakness following the ADP payrolls report.

2 set 2026, 23:51 UTC

Maximus Inc shares are higher in after-market trading, rebounding from earlier lows. Weaker ADP payroll data may ease concerns over aggressive Fed rate hikes.

2 set 2026, 23:51 UTC

New York Times Co shares are higher in after-market trading, supported by a solid market backdrop and recent ADP payrolls report indicating slower job growth.

2 set 2026, 23:51 UTC

Best Buy Co Inc shares are higher in after-market trading, supported by gains in the Computer & Electronics Retail sub-sector and maintaining a notable high.

2 set 2026, 23:51 UTC

U.S. equity indices rebound amid weak job growth and rising oil prices, while geopolitical tensions and climbing bond yields raise inflation concerns.

2 set 2026, 23:51 UTC

Asian equity markets decline amid U.S.-Iran tensions and rising bond yields, while U.S. stocks rebound ahead of key jobs data impacting Fed rate outlook.

Confronto tra pari

Modifica del prezzo

Theravance Biopharma Inc Previsione

Obiettivo di Prezzo

By TipRanks

-0.41% in calo

Previsioni per 12 mesi

Media 17 USD  -0.41%

Alto 17 USD

Basso 17 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Theravance Biopharma Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

3 ratings

0

Acquista

3

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Theravance Biopharma Inc

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). The company's product includes Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; and TRELEGY for the treatment of COPD and asthma. It has licensing and collaboration agreements with Pfizer Inc. for its preclinical skin-selective pan-JAK inhibitor program, as well as Viatris Inc. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
help-icon Live chat